Seacross Pharmaceutical Co.,Ltd

Seacross Pharmaceutical Ltd,located in UK, is the subsidiary of Sichuan Huiyu Pharmaceutical Co., Ltd which focused on developing and manufacturing or CMO high-quality oncology products. It was established by a group of Chinese and European veterans to bring high-quality, regulatory-compliant and cost-competitive products to meet the demands of the global healthcare industry. An efficient executive team across all functions including operation (manufacture, logistics, engineering etc.), R&D, regulatory, finance and marketing operations has already been established. Up to 380 Mn RMB is invested for the first phase of the whole construction project with 1 bln RMB occupying 100,000 sq.m. With the Ground Breaking in July 2011, Site Completion in September 2012 and validation batches made September 2013, we successfully obtained MHRA approval in April 2014 and Chinese CFDA approval in October 2014. Seacross as a MHRA approved drug marketing and registration agency, is aiming to offer MAs and wide range of oncology products dossiers to our clients.